Cloxazolam
![]() | |
![]() | |
| Clinical data | |
|---|---|
| Trade names | Akton, Cloxam, Clozal, Elum, Olcadil, and Sepazon[1] |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Elimination half-life | 65 hours |
| Excretion | Renal |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H14Cl2N2O2 |
| Molar mass | 349.21 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
Cloxazolam is a benzodiazepine derivative that has anxiolytic, sedative, and anticonvulsant properties. [2] It is not widely used; [2] as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan.[1] In 2019, it has been retired from the Belgian market. [3]
See also
References
- 1 2 "Cloxazolam International Brands". Drugs.com. Retrieved 13 August 2018.
- 1 2 Stolerman IP, ed. (2010). "C: Cloxazolam". Encyclopedia of Psychopharmacology. Berlin: Springer-Verlag. ISBN 978-3-540-68706-1.
- ↑ "Bon à savoir". cbip.be. Retrieved 13 August 2018.
External links
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

